References
- Rostom A, Muir K, Dubé C, Lanas A, Jolicoeur E, Tugwell P. Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf 2009;1:47–71.
- Rostom A, Muir K, Dubé C, Jolicoeur E, Boucher M, Joyce J, Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol 2007;5:818–28.
- Michaud K, Wolfe E. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:885–906.
- Myaseoedova E, Talley NJ, Manek NJ, Crowson CS. Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in Olmsted County, Minnesota. Gastroenterol Res Pract 2011;2011:745829.
- Kvien TK, Glennas A, Knudsrød OG, Smedstad LM, Mowinckel P, Forre O. The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol 1997;26:412–18.
- Kvien TK, T. Uhlig The Oslo experience with arthritis registries. Clin Exp Rhuematol 2003;31:315–24.
- Pincus T, Summey JA, Soraci SA Jr, Walleston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346–53.
- Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.
- Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 1989;32: 37–44.
- Lanas A, Garcia-Tell G, Armada B, Oteo-Alvaro A. Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. BMC Med 2011; 9:38.
- MacDonald TM, Morant SV, Goldstein JL, Burke TA, Pettitt D. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut 2003;52: 1265–70.